We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bipartisan Bill Would Allow Research on Schedule I Breakthrough Therapy Drugs
Bipartisan Bill Would Allow Research on Schedule I Breakthrough Therapy Drugs
Newly proposed bipartisan legislation would require the Drug Enforcement Administration (DEA) to reclassify psilocybin and MDMA (“Ecstasy”) from Schedule I to Schedule II drugs, relaxing some of the federal laws that have so far complicated research on strictly controlled psychoactive drugs.